Abstract:Abstract Introduction: Necroptosis is a cellular process known to be downregulated by cancer cells, and its molecular steps have been described in the literature. Mixed-lineage kinase domain like (MLKL) protein is the most terminal effector of necroptosis. Necroptosis has previously been shown to be activated by the formation of necrosome complex consisting of receptor interacting serine/threonine kinase 1 (RIPK1)-RIPK3-MLKL. MLKL is activated by RIPK3 via phosphorylation, forming phospho-MLKL (P-MLKL), leading to MLKL polymerization and cell necroptosis via lysosome membrane permeabilization (LMP) and plasma membrane rupture. We propose that the necrosome locates onto the lysosome, leading to MLKL-activation induced LMP before cell membrane rupture. Objectives: Our objective is to show that necrosome formation occurs on lysosomal membrane, which then leads to the formation of P-MLKL, and, subsequently, necroptosis via LMP and plasma membrane rupture. Methods: HT-29 cells with hemagglutinin (HA) tagged lysosomal transmembrane protein were induced to undergo necroptosis with the treatment of TNF (T), Smac-mimetic (S) and Z-VAD-FMK (Z) (abbreviated as T/S/Z). Lysosomes were extracted first by cell rupture via homogenization and then immunoprecipitation using anti-HA magnetic beads. Results: Our results suggest that LMP precedes plasma membrane permeability and that MLKL activation takes place on lysosomal membrane. Western blotting demonstrated that lysosomal cathepsin proteases, including CTSA, CTSB, CTSC, CTSD and CTSK, were released into cytosol during necroptosis, confirming lysosomal damage. Furthermore, P-RIPK1, P-RIPK3, P-MLKL and MLKL tetramer were found to be specifically associated with purified lysosomes upon necroptosis induction. Conclusions: MLKL activation on lysosomal membrane and LMP constitute an important step of necroptosis. [J.M. and R.F. contributed equally to this work.] Citation Format: Jamila Mammadova, Rojin Fatirkhorani, Shuzhen Liu, Ken Chen, Zhigao Wang. Necrosome translocates to lysosome to induce lysosome membrane permeabilization and subsequent necroptotic cell death [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2529.

LUBAC-mediated M1 Ub regulates necroptosis by segregating the cellular distribution of active MLKL

Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis

The MLKL Channel in Necroptosis is an Octamer Formed by Tetramers in a Dyadic Process.

Uncovering human mixed lineage kinase domain-like activation in necroptosis

Acylation of MLKL Impacts Its Function in Necroptosis

Abstract 2529: Necrosome translocates to lysosome to induce lysosome membrane permeabilization and subsequent necroptotic cell death

Surviving death: emerging concepts of RIPK3 and MLKL ubiquitination in the regulation of necroptosis

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis

Necrosome core machinery: MLKL

The Many Faces of MLKL, the Executor of Necroptosis

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

LUBAC enables tumor-promoting LTβ receptor signaling by activating canonical NF-κB

Mitochondrial Mechanisms of Necroptosis in Liver Diseases

Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis

TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis

Mlkl Knockout Mice Demonstrate the Indispensable Role of Mlkl in Necroptosis

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.